Forward Equity Partners

Global Healthcare Private Equity Firm

About us

Cross-border private equity firm focused on Healthcare / Life Science investments globally


Formerly Medivate Partners, Forward Equity Partners is a leading PE firm in Korea with proven track record in cross-border/healthcare transactions
What we do

We invest in innovative companies that provide essential technology and infrastructure for human health advancement

PEOPLE

Proven industry veterans

CEO & Managing PaRtner

Paul H. Kim

Advisory Partner

Alain Schreiber

ManAging partner

Hong Jun Park

Venture Partner

Alain Rolland

OUR LATEST UPDATEs

RIVA THERAPEUTICS

Series A-1 investment, Jun 2023

CMG Pharmaceuticals

Convertible Note investment, Mar 2023

SCAI THERAPEUTICS

Series B investment, Jul 2021

Numbers

Our growing figures

Current Investments
Exits in healthcare
0
PorTFOLIO

Featured Portfolio

COGNATE BIOSERVICES

Feb 2021, Acquired by Charles River Laboratories

GENOPIS, Inc.

Mar 2021, Acquired by Wacker Chemie AG

WCCT GLOBAL

Feb 2021, Acquired by Altasciences/Novo Holdings

SILLAJEN

Dec 2017, Exited in public market

Partnering with global entrepreneurs